Clinical trials and clinical practice--bridging the gaps in type 2 diabetes. An evidence-based approach to risk factor modification in type 2 diabetes

Aust N Z J Med. 2000 Aug;30(4):483-91. doi: 10.1111/j.1445-5994.2000.tb02056.x.
No abstract available

MeSH terms

  • Anticholesteremic Agents / therapeutic use
  • Antihypertensive Agents / therapeutic use
  • Atenolol / therapeutic use
  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Diabetes Mellitus, Type 2 / prevention & control
  • Diabetic Angiopathies / prevention & control*
  • Evidence-Based Medicine
  • Humans
  • Hypertension / prevention & control
  • Hypoglycemic Agents / therapeutic use
  • Metformin / therapeutic use
  • Myocardial Ischemia / prevention & control
  • Practice Guidelines as Topic
  • Pravastatin / therapeutic use
  • Risk Factors

Substances

  • Anticholesteremic Agents
  • Antihypertensive Agents
  • Hypoglycemic Agents
  • Atenolol
  • Metformin
  • Pravastatin